ForteBio Acquired by Pall Corporation

ForteBio, a venture backed company that makes instruments for biotech drug development, was acquired by Pall Corporation for an undisclosed sum. ForteBio produces systems that enable real-time analysis of biomolecular interactions. Based in Menlo Park, Forte has a wholly-owned manufacturing subsidiary in Shanghai's Zhangjiang Hi-Tech Park. More details.... Stock Symbol: (NYSE: PLL)     Share this with colleagues: